Valuation: Cannabis Bioscience International Holdings, Inc.

Market Cap 23.68L 21.04L 19.63L 17.9L 33.75L 23Cr 34.06L 2.38Cr 92.07L 12Cr 88.89L 86.96L 37Cr P/E 2024
-9.52x
P/E 2025 -11.8x
Enterprise Value 33.68L 29.92L 27.93L 25.46L 48.01L 32Cr 48.46L 3.38Cr 1.31Cr 17Cr 1.26Cr 1.24Cr 53Cr EV / Sales 2024
28.9x
EV / Sales 2025 25.6x
Free-Float
41.59%
Yield 2024 *
-
Yield 2025 -
15/07 Cannabis Bioscience International Holdings Receives Texas License for Consumable Hemp Products CI
17/04 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 CI
20/02 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025 CI
23/25/23 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 CI
06/25/06 Cannabis Bioscience International Holdings, Inc Appoints Andy Trivedi to Its Board of Directors CI
23/25/23 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025 CI
22/25/22 Cannabis Bioscience International Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
22/25/22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025 CI
22/25/22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 CI
06/25/06 Cannabis Bioscience International Holdings Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products CI
27/24/27 Cannabis Bioscience International Holdings, Inc. announced that it has received $0.075 million in funding CI
27/24/27 Cannabis Bioscience International Holdings, Inc. Appoints Charles Tamburello as Directors, Effective December 1, 2024 CI
25/24/25 Cannabis Bioscience International Holdings, Inc. Unveils the Future of Wellness with Revolutionary Anti-Aging Chip CI
1 week+100.00%
1 month+33.33%
3 months-33.33%
6 months-60.00%
Current year-60.00%
1 week 0
Extreme 0.00015
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 1.0E-6
0.27
Manager TitleAgeSince
Chief Executive Officer 70 19/12/2019
Treasurer 61 06/05/2024
Corporate Secretary 66 19/12/2019
Director TitleAgeSince
Director/Board Member 70 19/12/2019
Director/Board Member 66 19/12/2019
Director/Board Member 61 06/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+100.00%-60.00%-55.56% 24.13L
+4.16%+3.04%+49.37%+94.17% 7.42TCr
-3.11%-3.53%+20.19%+81.44% 5.74TCr
+0.89%-0.63%+2.17%+36.19% 4.76TCr
+0.36%+0.81%+342.39%+742.40% 4.43TCr
-0.96%-4.50%+24.96%+35.38% 4.25TCr
-0.20%-0.77%+4.13%+105.50% 4.07TCr
-0.54%+2.93%+9.31%+50.41% 3.1TCr
-2.68%+2.92%+29.33%+22.72% 2.85TCr
+0.05%-1.64%-8.14%-11.37% 2.43TCr
Average -0.20%+2.58%+41.37%+110.13% 3.91TCr
Weighted average by Cap. +0.12%-1.05%+56.96%+138.26%

Financials

2024 2025
Net sales 2L 2L 2L 2L 4L 2.39Cr 4L 24.97L 10L 1.22Cr 9L 9L 3.92Cr 3L 3L 3L 2L 4L 2.91Cr 4L 30.41L 11.78L 1.49Cr 11.38L 11.13L 4.78Cr
Net income -7L -6L -5L -5L -9L -6.26Cr -9L -65.37L -25.33L -3.2Cr -24.45L -23.92L -10Cr -5L -5L -5L -4L -8L -5.28Cr -8L -55.08L -21.34L -2.7Cr -20.61L -20.16L -8.66Cr
Net Debt 9L 8L 8L 7L 13.39L 9.03Cr 13.52L 94.27L 36.53L 4.62Cr 35.27L 34.5L 15Cr 10L 9L 8L 8L 14.26L 9.62Cr 14.39L 1Cr 38.9L 4.92Cr 37.56L 36.75L 16Cr
Logo Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.
Employees
2
Date Price Change Volume
30/26/30 $0.000200 -.--% 20,000
28/26/28 $0.000200 +100.00% 30,000
25/26/25 $0.000100 -.--% 10,11,999
  1. Stock Market
  2. Stocks
  3. CBIH Stock